Autopilot 2.0 Chain AI agents into full outbound flows Read more →
Product
AI Sales Agents Prospector Intent & Signals Visitor Tracking Reply Handler Email Automation LinkedIn Automation Autopilot
Solutions
TAM sourcing Automated outbound Sales RevOps Enterprise Startups
Resources
The Report Blog Salestools University Guides GPT Prompts ROI Calculator Help Center
Company
Our Team Careers Customers Partner Program Pricing Changelog
Language
Get a demo Start free trial Log in

Rapporten

Djupdykningar i företagsfinansiering, tillväxtstrategier och marknadsinsikter från världens mest innovativa företag

2 rapporter och fler

Uppdateras dagligen med senaste marknadsintelligens
Fundraising
Lyell Immunopharma

Lyell Immunopharma Raises $425M in Series C

Lyell Immunopharma, a Biotech company based in 201 Haskins Way, South San Francisco, CA 94080, has raised $425M in Series C at a $1.4B valuation led by GV, F-Prime Capital, Bain Capital Life Sciences, Patient Square Capital, Bristol Myers Squibb.

Fundraising News Team
Mar 9, 2024
0 min read
Biotech
Lyell Immunopharma

Lyell Immunopharma raises $425M Series C at $1.4B valuation

Lyell Immunopharma raises $425M in Series C at $1.4B valuation. T-cell reprogramming for solid tumors...

Editorial Team
Mar 9, 2024
0 min read•$425M
Sida 1

Visar 2 rapporter • Sida 1 • Kategori: all

Ligga steget före marknaden

Få veckovisa insikter levererade till din inkorg. Ingen spam, bara intelligens.